ArticleInvestigational new drugs2020

Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non-small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study.

Hayato Kawachi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.